90 related articles for article (PubMed ID: 3929268)
1. EORTC Phase II chemotherapy studies in prostate cancer.
Jones WG
Prog Clin Biol Res; 1985; 185A():435-45. PubMed ID: 3929268
[No Abstract] [Full Text] [Related]
2. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin-associated lung disease.
Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
[No Abstract] [Full Text] [Related]
4. An EORTC phase II study of vindesine in advanced prostate cancer.
Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Joss RA; Brunner KW; Goldhirsch A
Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
[No Abstract] [Full Text] [Related]
6. Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
Schroeder FH
Prostate; 1984; 5(2):193-8. PubMed ID: 6231535
[TBL] [Abstract][Full Text] [Related]
7. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
8. Phase II trial of vindesine in advanced gastric cancer.
Kenny JB; Scarffe JH; Maley WV
Cancer Treat Rep; 1983 Jan; 67(1):89-90. PubMed ID: 6311414
[No Abstract] [Full Text] [Related]
9. [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Chauvergne J; Durand M; Brunet R; Bui BN; Hoerni B; Mauriac L
Bull Cancer; 1981; 68(5):442-8. PubMed ID: 6800426
[TBL] [Abstract][Full Text] [Related]
10. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
12. Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.
Luedke D; McLaughlin TT; Daughaday C; Luedke S; Harrison B; Reed G; Martello O
Cancer; 1985 Feb; 55(3):542-5. PubMed ID: 3917366
[TBL] [Abstract][Full Text] [Related]
13. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
Saiers JH; Slavik M; McKinney DR
Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
[No Abstract] [Full Text] [Related]
15. Phase II trial of vindesine in adenocarcinoma of the lung.
Sledge GW; Clark GM; Von Hoff DD
Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
[No Abstract] [Full Text] [Related]
16. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
[No Abstract] [Full Text] [Related]
17. Phase II trial of vindesine in patients with small cell lung carcinoma.
Natale RB; Gralla RJ; Wittes RE
Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
[No Abstract] [Full Text] [Related]
18. Phase II study of vindesine in metastatic malignant melanoma.
Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
[No Abstract] [Full Text] [Related]
19. Phase II trial of vindesine in patients with malignant melanoma.
Camacho FJ; Young CW; Wittes RE
Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
[No Abstract] [Full Text] [Related]
20. Phase II trial of vindesine in advanced head and neck cancer.
Cheng E; Young CW; Wittes RE
Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
